Patient-reported outcomes (PROs) from the phase III IMpassion130 trial of atezolizumab (atezo) plus nabpaclitaxel (nP) in metastatic triple-negative breast cancer (mTNBC).

Sylvia Adams, Veronique Dieras, Carlos H Barrios, Eric P Winer, Andreas Schneeweiss, Hiroji Iwata, Sherene Loi, Sheetal Patel, Volkmar Henschel, Stephen Y Chui, Hope S Rugo, Leisha A Emens, Peter Schmid